Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Wierenga Wendell received 5,925 Crinetics Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 18, 2026 · Filed Jun 22, 2026

On Jun 18, 2026, Wierenga Wendell (Director) received 5,925 Crinetics Pharmaceuticals, Inc. shares as an award, leaving 122,071 shares. Filed Jun 22, 2026 (Form 4).

Awarded
5,925 shares
Holding after
122,071 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockAward5,925122,071Direct

Source

View original at SEC

Related